- Home
- ATOS vs NXPL Comparison
ATOS vs NXPL Comparison
Compare ATOS & NXPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ATOS | NXPL |
|---|---|---|
| Founded | 2009 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.4M | 25.8M |
| IPO Year | 2010 | 2011 |
Fundamental Metrics
Financial Performance| Metric | ATOS | NXPL |
|---|---|---|
| Price | $2.63 | $8.50 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $19.00 | N/A |
| AVG Volume (30 Days) | ★ 96.2K | 10.0K |
| Earning Date | 11-11-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 35.29 |
| EPS | N/A | ★ N/A |
| Revenue | $1,758.00 | ★ $5,869,558.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $46.77 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 2.50 |
| 52 Week Low | $0.53 | $0.34 |
| 52 Week High | $7.56 | $11.10 |
Technical Indicators
Market Signals| Indicator | ATOS | NXPL |
|---|---|---|
| Relative Strength Index (RSI) | 55.41 | 38.96 |
| Support Level | $2.32 | $5.53 |
| Resistance Level | $3.04 | $8.37 |
| Average True Range (ATR) | 0.28 | 0.71 |
| MACD | 0.02 | -0.11 |
| Stochastic Oscillator | 52.50 | 19.22 |
Price Performance
Historical ComparisonAbout ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of proprietary medicines for oncology, with a focus on breast cancer and related conditions. The company's lead product candidate, oral (Z)-endoxifen, is a selective estrogen receptor modulator and degrader (SERM/SERD) in Phase 2 clinical development, being evaluated for the treatment and prevention of breast cancer and other indications.
About NXPL NextPlat Corp
NextPlat Corp is an e-commerce and healthcare company. The company operates in two segments: e-Commerce Operations involves acquiring and leasing an e-commerce platform; and Healthcare Operations provides TPA, data management, COVID-19 related diagnostics and vaccinations, prescription pharmaceuticals, and Others.